Biote to announce Q2 2026 financial results on August 5
Biote will announce its Q2 2026 financial results on August 5, 2026, followed by a conference call at 5:00 p.m. ET. The company specializes in hormone optimization and healthy aging solutions.

*this image is generated using AI for illustrative purposes only.
Biote will release its second quarter 2026 financial results on Wednesday, August 5, 2026, after the market closes. The company, which specializes in hormone optimization and healthy aging solutions, will host a conference call at 5:00 p.m. ET on the same day to discuss its performance.
Conference Call Details
Investors can access the conference call by dialing (646) 307-1963 (U.S. toll-free) or (800) 715-9871 (International) and using conference ID 1792102. A live webcast will be available via the Biote Corp. Second Quarter Earnings Call link. A replay of the webcast will be accessible on the Events page of the Biote Investor Relations website shortly after the event concludes.
About Biote
Biote focuses on advancing the healthspan of patients through innovative hormone optimization and healthy aging solutions. The company collaborates with certified providers and clinicians to restore vitality and promote vibrant aging.
What key metrics will investors be watching to gauge Biote's growth in the hormone optimization market?
How might Biote's performance in Q2 2026 reflect broader trends in the healthy aging industry?
What strategic initiatives could Biote announce to expand its provider network or product offerings?
























